There are few studies comparing the economic costs and reimbursements for aneurysm clipping versus coiling, and none are from the United States. Our hypothesis predicted that coiling would result in shorter lengths of hospitalization than clipping in patients with unruptured aneurysms and would therefore result in lower hospital charges. However, because of the severity of subarachnoid hemorrhage, there would be no difference in length of hospitalization or hospital charges in patients with ruptured aneurysms.
E
ndovascular coil embolization as an alternative to open microsurgical clipping has increasingly been used as a primary treatment of cerebral aneurysms since its introduction in 1990 (16) and its approval by the U.S. Food and Drug Administration in 1995. The International Subarachnoid Aneurysm Trial (ISAT) (6, 22, 23) and numerous other studies (1, 3-5, 7-15, 18, 20, 21, 24, 28, 29, 31, 32) have compared coiling with clipping of cerebral aneurysms in terms of patient survival, dependency, rebleeding, retreatment, hydrocephalus, neurocognition, cranial nerve palsy, and other clinical outcome indices. Only a few economic comparison studies of coiling versus clipping are reported in medical literature; however, none are from the United States where health care costs, reimbursement, and payor systems are different from those in Europe, Canada, and Australia (2, 17, 19, 25, 33) . Economic considerations are important in the cost-benefit evaluation of therapies and can influence reimbursement coverage decisions and policies. At the University of Florida, both coiling and clipping are performed by the same neurovascular team. We retrospectively compared coiling with clipping at our institution in terms of length of hospitalization, hospital costs, hospital billing, hospital collections, surgeon billing, and surgeon collections. We thought that it was important to study patients with unruptured aneurysms as well as those with ruptured aneurysms to reflect the practice pattern of an academic neurovascular center. Additionally, a direct comparison demonstrating a difference between coiling and clipping is necessary in a cohort of patients with unruptured aneurysms, whereas patients with ruptured aneurysms can have multiple complicating factors such as the severity of the presenting neurological condition, which can significantly affect length of hospitalization and hospital costs.
Our hypothesis was that coiling would result in shorter lengths of hospitalization than clipping in patients with unruptured aneurysms and, thus, result in lower hospital charges, but that, because of the disease severity of subarachnoid hemorrhage (SAH), there would be no difference in length of hospitalization or hospital charges in patients with ruptured aneurysms.
PATIENTS AND METHODS
This study was performed using a protocol approved by the Institutional Review Board at the University of Florida and in accordance with patient privacy rights protection as enforced by the Health Insurance Portability and Accountability Act.
Patients with cerebral aneurysms treated either surgically or endovascularly at the University of 
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(WFNS Grade 3), and poor (WFNS Grades 4-5). Length of hospitalization, hospital costs, hospital billing, hospital collections, surgeon billing, surgeon collections, and payor data were collected from the hospital's economic utilization database. Hospital costs data were obtained from the hospital cost accounting system, which determines the total costs incurred for each service provided (e.g., intensive care unit, pharmacy, ancillary services). These costs include not only direct caregiver activity, but also registration, billing, human resources, and other indirect hospital operational costs. The hospital provided the total inpatient surgical episode cost data for each patient.
With the skewness nature of economic data, we chose to use quartile-based statistics, median and interquartile range (IQR), to summarize the distribution of length of hospitalization, hospital costs, hospital billing, hospital collections, surgeon billing, and surgeon collections. An IQR is the difference between the first and third quartiles of the data and can be used as a measure of variation. A larger value of IQR indicates wider spread of the data. Because the hospital considers its costs and collections proprietary information, all cost impacts and collections are reported as ratio changes in medians and IQRs or as incremental dollar amounts.
The Mantel-Haenszel test and nonparametric Wilcoxon rank-sum test were performed to compare demographic and aneurysm characteristics between the surgically and endovascularly treated groups. The differences in length of hospitalization, hospital costs, hospital collections, and surgeon collections between the 2 treatment groups were summarized and compared by their medians and IQRs. Log-normal models of length for hospitalization and hospital costs and gamma models for hospital and surgeon collections were chosen to estimate and infer the effects of important factors including age, sex, treatment procedure (surgery or endovascular treatment), aneurysm size, aneurysm location (anterior circulation or posterior circulation), and payor. For each outcome, 2 separate models were fitted for ruptured and unruptured cerebral aneurysms. The form of each specific model was selected after a proper residual analysis or goodness-of-fit test. The logarithm-transformed length of hospitalization was included in models for hospital costs, hospital collections, and surgeon collections. In addition, the logarithm-transformed hospital billing was considered in the model for hospital collections, and the logarithm-transformed surgeon billing was considered in the model for surgeon collections. A Type I error rate of 0.025 was considered after Bonferroni correction for 2 simultaneous models for patients with and without SAH.
RESULTS
During the time period studied, there were 565 patients with cerebral aneurysms treated either surgically (306 patients, 54%) or endovascularly (259 patients, 46%). The demographic characteristics of the patients are shown in Table 1 . There were 3 patients with SAH whose clinical grade could not be determined retrospectively from the medical records. The characteristics of the cerebral aneurysms treated are given in Table 2 .
Comparison of Surgery and Endovascular Treatment
In patients without SAH (unruptured cerebral aneurysms), the surgical group compared with the endovascular group in multivariate analysis after adjusting for all other factors in the model was associated with a longer median hospitalization (P Ͻ 0.001), but a lower median hospital cost (P Ͻ 0.001) and higher surgeon collections (P ϭ 0.003) ( difference in hospital collections between the surgically and endovascularly treated groups.
In patients with SAH (ruptured cerebral aneurysms), the surgical group in the multivariate analysis after adjusting for all other factors in the model was associated with a lower median hospital cost (P ϭ 0.011) ( Table 4 ). There was no difference in the length of hospitalization, hospital collections, or surgeon collections.
Patients without SAH
In patients without SAH (unruptured cerebral aneurysms), factors significantly associated with the length of hospitalization in the multivariate analysis were sex (P ϭ 0.012), payor (P Ͻ 0.001), aneurysm size (P Ͻ 0.001), and treatment (P Ͻ 0.001). After adjusting for all other factors in the model, surgical treatment, male sex, and larger aneurysm size were associated with longer hospitalization. Patients with Medicaid or a self-pay payor were associated with longer hospitalization.
Factors significantly associated with hospital costs in the multivariate analysis were length of hospitalization (P Ͻ 0.001), age (P ϭ 0.018), aneurysm size (P Ͻ 0.001), and treatment (P Ͻ 0.001). After adjusting for all other factors in the model, endovascular treatment, older age, patients with longer hospitalization, and larger aneurysm size were associated with higher hospital costs.
Factors significantly associated with hospital collections in the multivariate analysis were hospital billing (P Ͻ 0.001) and payor (P Ͻ 0.001). After adjusting for all other factors in the model, higher hospital billing was associated with higher hospital collections. Patients with a self-pay payor were associated with lower hospital collections.
Factors significantly associated with surgeon collections in the multivariate analysis were surgeon billing (P Ͻ 0.001), payor (P Ͻ 0.001), and treatment (P ϭ 0.003). After adjusting for all other factors in the model, surgery and higher surgeon billing were associated with higher surgeon collections. Patients with commercial and managed care payor were asso- ciated with higher surgeon collections, whereas patients with a self-pay payor were associated with lower surgeon collections.
Patients with SAH
In the univariate analysis, SAH (ruptured cerebral aneurysms) was significantly associated with longer hospitalizations, higher hospital costs, and higher hospital collections regardless of the treatment. Patients with SAH were associated with a 6.3 times longer median length of hospitalization, 3.2 times higher median hospital costs, 1.6 times higher median hospital collections, and 0.8 times lower median surgeon collections compared with patients without SAH.
Surgery for patients with SAH was associated with a 4.5 times longer median length of hospitalization, 3.5 times higher median hospital costs, 3.4 times higher median hospital collections, and 0.9 times lower median surgeon collections than surgery for patients without SAH. Endovascular treatment for patients with SAH was associated with a 19 times longer median length of hospitalization, 3.6 times higher median hospital costs, and 3.3 times higher median hospital collections than endovascular treatment for patients without SAH.
In the multivariate analysis, the only factor significantly associated with the length of hospitalization was the payor (P Յ 0.001); Medicaid and Medicare patients were associated with longer hospitalization. Factors significantly associated with hospital costs in the multivariate analysis were the length of hospitalization (P Յ 0.001), payor (P ϭ 0.034), aneurysm size (P ϭ 0.015), clinical grade (P Ͻ 0.001), and treatment (P ϭ 0.011). After adjusting for all other factors in the model, endovascular treatment, longer hospitalization, larger aneurysm size, worse clinical grade, and payor (programs, health maintenance organization, Medicaid maintenance organization, Medicare maintenance organization) were associated with higher hospital costs. Factors significantly associated with higher hospital collections in the multivariate analysis were the payor (P Ͻ 0.001) and posterior circulation location of aneurysms (P ϭ 0.047). After adjusting for all other factors in the model, posterior circulation location of the aneurysm was associated with higher hospital collections. Patients with a self-pay payor were associated with lower hospital collections.
Factors significantly associated with surgeon collections was the payor (P Ͻ 0.001) and posterior circulation location of the aneurysm (P ϭ 0.016). After adjusting for all other factors in the model, posterior circulation location was associated with higher surgeon collections. Patients with Medicaid and a selfpay payor were associated with lower surgeon collections.
DISCUSSION
Previous studies, including the ISAT studies (6, 22, 23) and others (1, 3-5, 7-15, 18, 20, 21, 24, 28, 29, 31, 32) , compared the clinical outcomes of patients with cerebral aneurysms that were treated surgically or endovascularly. There are relatively few studies that compared the economic costs of surgery and those of endovascular treatment. Economic cost-benefit analysis of different surgical and endovascular treatment options is becoming increasingly important in the current health care environment of constrained resources and increasing costs. The economic costs associated with SAH alone are enormous in the United States health care system. The lifetime economic health care cost of an individual in the United States affected by SAH has been calculated to be $228 030 (the highest among all stroke subtypes). The aggregate lifetime costs for all individuals affected by SAH in the United States in 1 year have been calculated to be $5.6 billion (30).
Our hypothesis was that coiling would result in shorter hospitalizations than clipping in patients with unruptured aneurysms and would therefore result in lower hospital charges; however, because of the disease severity of SAH, there would be no difference in length of hospitalization or hospital charges in patients with ruptured aneurysms. The findings of our study revealed, however, that despite a shorter length of stay in patients with unruptured aneurysms, coiling was associated with higher hospital costs in both patients with unruptured and ruptured aneurysms. We believe this is likely attributable to the higher device cost of coils.
The relatively few studies comparing the costs of coiling with those of clipping do not compare costs in the United States, and all studies but one were of patients with SAH (2, 17, 19, 25, 33). Wolstenholme et al. (33) reported a comparison of the hospital costs for coiling compared with those for clipping for patients enrolled in the ISAT at 22 centers in the United Kingdom. They found that there was no significant difference in hospital costs between patients treated endovascularly and those treated surgically at the 12-and 24-month follow-up examinations. The endovascularly treated patients initially had lower hospital costs than the surgically treated patients associated with the shorter length of hospitalization for the initial procedure; however, this was offset by the higher costs for the endovascularly treated patients for subsequent procedures, angiograms, complications, and adverse events in the subsequent 12-to 24-month period.
Javadpour et al. (19) reported a comparison of hospital costs for ISAT patients at their institution in Toronto, Canada. They found that there was no significant difference in costs between endovascularly treated patients and surgically treated patients. The benefit of a shorter length of hospitalization seen in the endovascularly treated patients was offset by the higher procedure costs of endovascular treatment. Bairstow et al. (2) compared hospital costs for ISAT patients enrolled at 2 hospitals in Perth, Western Australia. They found that hospital costs were lower for endovascularly treated patients than for surgically treated patients. Although the endovascular procedures were more expensive in terms of the cost of consumables, the total costs were lower than for surgically treated patients because of the lower staffing costs and lower cost of postprocedure hospitalization.
Halkes et al. (17) reported a comparison of costs of coiling and clipping in patients with unruptured aneurysms treated at their institution in Utrecht, the Netherlands, and found that, on average, the total cost of coiling was higher than that for clipping. Although clipping had higher costs related to the need for intensive care facilities and longer length of hospitalization, this was more than offset by the higher material cost of coils.
Ours is the first study that compares the length of hospitalization and economic costs of surgery versus endovascular therapy for unruptured and ruptured cerebral aneurysms at a medical center in the United States. Our study results demonstrate that for patients with unruptured cerebral aneurysms, endovascular therapy, as opposed to surgery, is associated with shorter length of hospitalization, but higher hospital costs and lower surgeon collections, while hospital collections were similar. For patients with SAH from ruptured cerebral aneurysms, endo vas cular therapy, as opposed to surgery, was associated with higher hospital costs; length of hospitalization, hospital collections, while surgeon collections were similar.
Our model demonstrates that length of hospitalization is directly associated with hospital costs; thus, despite a shorter (for patients with unruptured aneurysms) or similar (for patients with ruptured aneurysms) length of hospitalization with endovascular treatment compared with surgery, endovascular treatment was still associated with significantly higher costs to the hospital. Because our postoperative, in-hospital management of patients with ruptured aneurysms is similar whether they are treated with clipping or coiling and our in-hospital management of patients with unruptured aneurysms is shorter after coiling, the higher hospital costs with coiling must be attributable to the higher device cost of coils than clips, which is substantiated by other studies in the literature (2, 17, 19) .
The higher hospital costs of coiling compared with clipping highlights the common dilemma of the higher cost of new technology. Although coiling may have resulted in shorter hospitalizations in the patients with unruptured aneurysms, because it is a newer technology, the higher device cost of coils translated to higher costs to the hospital. Furthermore, SAH was the most powerful factor significantly influencing the length of hospitalization, hospital costs, and hospital collections.
Interestingly, larger aneurysm size is known to be a significant factor influencing clinical patient outcomes after aneurysm HOH ET AL. treatment (26, 27) and, in this study, was significantly associated with longer length of hospitalization in patients with unruptured aneurysms and higher hospital costs in both patients with unruptured and ruptured aneurysms.
Posterior circulation location of an aneurysm is a factor recognized to significantly influence clinical patient outcomes (26, 27) , but was not found to be a significant factor for length of hospitalization or hospital costs in this study. Likewise, older age is recognized to significantly influence clinical patient outcomes (26, 27) , but was only associated with higher hospital costs in patients with unruptured aneurysms in this study.
The payor was significantly associated with length of hospitalization in patients with ruptured aneurysms and higher hospital costs in both patients with unruptured and ruptured aneurysms, likely serving as an index reflecting socioeconomic status, age, and/or premorbid health. The payor was also significantly associated with surgeon collections in patients with ruptured aneurysms, likely reflecting reimbursement patterns among different payors. As expected, we also found that worse clinical grade was significantly associated with higher hospital costs.
The limitations of this study include its retrospective nature. Patients were not randomized to clipping or coiling. Thus, there was a significant difference between the cohorts in terms of age, payor, aneurysm size, and aneurysm location (Tables 1  and 2 ). We attempted to address the selection bias by considering these and other related factors in the multivariate models for length of hospitalization, hospital costs, hospital collections, and surgeon collections. If there is any lurking factor overlooked by the model, the comparison of clipping and coiling may be problematic.
Additionally, there may be higher costs with endovascular treatment related to subsequent procedures and follow-up angiograms, which were not found in our study, but were reported by Wolstenholme et al. (33) .
Finally, these findings represent only one academic medical center in the southeast United States. Practice patterns, patient demographics, payor mix, hospital costs, and reimbursement vary widely geographically and among different size and level medical centers, and the findings of this study might not be generalizable to the entire United States. However, we believe that our study is the first to determine the differences in economic costs between surgery and endovascular treatment for patients with unruptured and ruptured aneurysms and will perhaps lead to further investigations.
CONCLUSION
We found that the advantages of coiling over clipping would be better realized if the cost of coils could be reduced to be comparable to the cost of clips.
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T he authors of this study evaluated coiling and clipping, comparing the cost, the length of stay, and other factors in patients treated endovascularly versus surgically. They treated 306 patients surgically and 259 patients endovascularly; patients with unruptured aneurysms were also included in the study.
Their findings differed somewhat from those of a study performed at our institution as part of a thesis for a master of public health; data from that study are shown in Table C1 . Our findings were actually quite different. Whereas length of stay was almost identical in subarachnoid hemorrhage patients, those with unruptured lesions who were treated endovascularly had a shorter length of stay. Whether the aneurysms were ruptured or unruptured, the cost at our institution was between $20 000 and $30 000 less in endovascularly treated patients than in those treated surgically. We did not evaluate physician reimbursement, although, in general, the reimbursement in our area is less for endovascular procedures as compared with open cranial surgery. Although the cost of devices is greater than surgical treatment, the reduction in cost was primarily related to reduced length of stay. This is an important issue, as the economics certainly drive the system but clearly relate to the cost in different geographic regions and payor reimbursement.
Robert H. Rosenwasser
Philadelphia, Pennsylvania I n this study, Hoh et al. analyzed hospital costs and surgeon collections associated with endovascular or surgical treatment of ruptured and unruptured intracranial aneurysms. The study suggests that, despite a shorter inpatient stay for patients with unruptured aneurysms, hospital costs were higher in the endovascular as opposed to the surgical group. In the group of patients with ruptured intracranial aneurysms, there were no significant differences in the length of stay, but again, hospital costs were higher in the endovascular group. Higher costs in the endovascular group were related primarily to higher costs of devices (i.e., coils).
This study provides a snapshot of hospital costs associated with the treatment of ruptured and unruptured intracranial aneurysms at the authors' institution. Studies like this are important, as external forces will stress economic factors in health care delivery. This and similar studies should increase our awareness about costs associated with endovascular procedures. Too often, newer and often more expensive devices are preferred to "traditional" ones, despite lack of evidence of improved long-term angiographic or clinical outcomes.
This study has important limitations, and these conclusions must be taken with caution. The endovascular and surgical groups were not comparable. As shown in Table 1 of the article, patients in the endovascular group were older and more often harbored posterior circulation aneurysms. Similarly, the percentage of patients in fair or poor clinical grade at admission was higher in the endovascular group. Length of stay was calculated as time (days) spent at the authors' institution. It is not uncommon in tertiary referral centers to transfer patients to rehabilitation facilities or skilled nursing facilities as soon as patients are stable and do not require acute inpatient care. We do not have any information regarding costs associated with stays in these facilities and how the treatment modality might have affected these additional and significant costs.
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